Generalized Anxiety Disorder Market: Report Unveils Insightful Epidemiology and Treatment Dynamics by 2032
February 02, 2024 07:12 ET
|
Research and Markets
Dublin, Feb. 02, 2024 (GLOBE NEWSWIRE) -- The "Generalized Anxiety Disorder Market Insight, Epidemiology and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. In...
Second Generation Anti-Epileptic Drugs (AEDs) Dominate the Market in 2022, While Third Generation AEDs Projected to Exhibit the Fastest Growth
November 06, 2023 06:58 ET
|
Research and Markets
Dublin, Nov. 06, 2023 (GLOBE NEWSWIRE) -- The "Global Anti-Epileptic Drugs Market: Analysis By Drug Generation, By Distribution Channel, By Region Size and Trends with Impact of COVID-19 and...
Peripheral Neuropathy Treatment Market Report 2022: Featuring Abbott, Eli Lilly, Pfizer, NeuroBo, Teva & Others
September 23, 2022 06:53 ET
|
Research and Markets
Dublin, Sept. 23, 2022 (GLOBE NEWSWIRE) -- The "Peripheral Neuropathy Treatment Market, by Indication, by Treatment and Non-Pharmacological Therapies, by End-user, and by Region - Size, Share,...
Chemotherapy-Induced Peripheral Neuropathy (CIPN) Market to Cross $1.52 Billion by 2030 - What Are the Most Investment-Attractive Products, Segments, Applications, and Areas?
March 15, 2022 05:08 ET
|
Research and Markets
Dublin, March 15, 2022 (GLOBE NEWSWIRE) -- The "Global Chemotherapy-Induced Peripheral Neuropathy Market, By Therapy, By Region, Estimation & Forecast, 2017 - 2030" report has been added to...
Insights on the Cancer Pain Global Market to 2030 - Rising Healthcare Expenditure and Government Support Worldwide are Driving Growth
March 09, 2022 04:58 ET
|
Research and Markets
Dublin, March 09, 2022 (GLOBE NEWSWIRE) -- The "Global Cancer Pain Market, By Drug Type, By Disease Indication, Estimation & Forecast, 2017 - 2030" report has been added to...